MedPro Healthcare Staffing Named Top Corporate Team of the Year for Light The Night, South Florida, Raising $37,255 to Support the Leukemia & Lymphoma Society GlobeNewswire November 05, 2025 Sunrise, Florida, Nov. 05, 2025 (GLOBE NEWSWIRE) — MedPro Healthcare Staffing was named Top Corporate Team of the Year at the 2025 Light The Night South […]

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ:TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug,

Rochester, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) — Carestream Health is excited to showcase the award-winning, customer-first solutions behind its versatile portfolio of X-ray imaging solutions at the Radiologic Society of North America (RSNA) Annual Conference from November 30-December 4, 2025, in Chicago. Attendees can visit Booth #2154 in the South Hall to learn how

Carestream to Showcase Award-Winning Innovation and New Products at RSNA 2025 GlobeNewswire November 05, 2025 Rochester, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) — Carestream Health is excited to showcase the award-winning, customer-first solutions behind its versatile portfolio of X-ray imaging solutions at the Radiologic Society of North America (RSNA) Annual Conference from November 30-December 4,

(NASDAQ:ATYR), SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) — A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The firm urges investors in aTyr who suffered significant losses to submit your losses

aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged — Hagens Berman ATYR Investors with Losses Encouraged to Contact the Firm GlobeNewswire November 05, 2025 SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) — A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Arcturus Therapeutics Holdings Inc. ("Arcturus Therapeutics Holdings Inc.") (NASDAQ:ARCT) concerning possible violations of federal securities laws. Arcturus issued a press release on October 22, 2025, "announc[ing] interim results from its ongoing Phase

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sonic Automotive, Inc. ("Sonic Automotive, Inc.") (NYSE:SAH) concerning possible violations of federal securities laws. Sonic Automotive reported its financial results for the third quarter of 2025 on October 23, 2025. Among other

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alexandria Real Estate Equities, Inc. ("Alexandria Real Estate Equities, Inc.") (NYSE:ARE) concerning possible violations of federal securities laws. Alexandria issued a press release on October 27, 2025, reporting its financial results for